Pediatrix Medical Group Statistics
Total Valuation
MD has a market cap or net worth of $1.28 billion. The enterprise value is $1.74 billion.
Important Dates
The last earnings date was Friday, November 1, 2024, before market open.
| Earnings Date | Nov 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MD has 84.52 million shares outstanding. The number of shares has increased by 0.79% in one year.
| Shares Outstanding | 84.52M |
| Shares Change (YoY) | +0.79% |
| Shares Change (QoQ) | +1.43% |
| Owned by Insiders (%) | 1.57% |
| Owned by Institutions (%) | 93.83% |
| Float | 74.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 10.28 |
| PS Ratio | 0.63 |
| Forward PS | 0.61 |
| PB Ratio | 1.75 |
| P/FCF Ratio | 11.11 |
| PEG Ratio | 1.43 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.76, with an EV/FCF ratio of 15.13.
| EV / Earnings | n/a |
| EV / Sales | 0.87 |
| EV / EBITDA | 8.76 |
| EV / EBIT | 10.59 |
| EV / FCF | 15.13 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.93.
| Current Ratio | 1.42 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | 2.96 |
| Debt / FCF | 5.94 |
| Interest Coverage | 4.00 |
Financial Efficiency
Return on equity (ROE) is -29.85% and return on invested capital (ROIC) is 6.66%.
| Return on Equity (ROE) | -29.85% |
| Return on Assets (ROA) | 4.67% |
| Return on Capital (ROIC) | 6.66% |
| Revenue Per Employee | $368,257 |
| Profits Per Employee | -$46,575 |
| Employee Count | 5,450 |
| Asset Turnover | 0.91 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -19.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +52.02% in the last 52 weeks. The beta is 1.55, so MD's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | +52.02% |
| 50-Day Moving Average | 11.71 |
| 200-Day Moving Average | 9.41 |
| Relative Strength Index (RSI) | 75.63 |
| Average Volume (20 Days) | 703,749 |
Short Selling Information
The latest short interest is 4.39 million, so 5.19% of the outstanding shares have been sold short.
| Short Interest | 4.39M |
| Short Previous Month | 4.79M |
| Short % of Shares Out | 5.19% |
| Short % of Float | 5.85% |
| Short Ratio (days to cover) | 7.19 |
Income Statement
In the last 12 months, MD had revenue of $2.01 billion and -$253.84 million in losses. Loss per share was -$3.06.
| Revenue | 2.01B |
| Gross Profit | 426.99M |
| Operating Income | 164.62M |
| Pretax Income | -267.92M |
| Net Income | -253.84M |
| EBITDA | 199.04M |
| EBIT | 164.62M |
| Loss Per Share | -$3.06 |
Full Income StatementBalance Sheet
The company has $220.45 million in cash and $683.65 million in debt, giving a net cash position of -$463.20 million or -$5.48 per share.
| Cash & Cash Equivalents | 220.45M |
| Total Debt | 683.65M |
| Net Cash | -463.20M |
| Net Cash Per Share | -$5.48 |
| Equity (Book Value) | 732.49M |
| Book Value Per Share | 8.67 |
| Working Capital | 155.14M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $142.81 million and capital expenditures -$27.63 million, giving a free cash flow of $115.19 million.
| Operating Cash Flow | 142.81M |
| Capital Expenditures | -27.63M |
| Free Cash Flow | 115.19M |
| FCF Per Share | $1.36 |
Full Cash Flow StatementMargins
Gross margin is 21.27%, with operating and profit margins of 8.20% and -12.65%.
| Gross Margin | 21.27% |
| Operating Margin | 8.20% |
| Pretax Margin | -13.63% |
| Profit Margin | -12.65% |
| EBITDA Margin | 9.92% |
| EBIT Margin | 8.20% |
| FCF Margin | 5.02% |
Dividends & Yields
MD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.79% |
| Shareholder Yield | -0.79% |
| Earnings Yield | -19.84% |
| FCF Yield | 9.00% |
Dividend DetailsAnalyst Forecast
The average price target for MD is $13.25, which is -12.48% lower than the current price. The consensus rating is "Hold".
| Price Target | $13.25 |
| Price Target Difference | -12.48% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 20, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Dec 20, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
MD has an Altman Z-Score of 1.48 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.48 |
| Piotroski F-Score | 6 |